India Pharma Outlook Team | Monday, 09 March 2026
HLL Lifecare is set to strengthen its retail presence with an ambitious plan to expand its Amrit Pharmacy chain to 550 outlets across India by 2027.
Currently operating around 200 stores, the company aims to make affordable medicines and health products more accessible, particularly in tier-2 and tier-3 cities.
The expansion is aimed at strengthening the government’s efforts to provide affordable and accessible healthcare, the Kerala-based PSU said in a statement.
The expansion comes as part of HLL Lifecare’s strategy to increase its reach in the healthcare sector and provide reliable pharmaceutical services to a wider population. “This balanced regional distribution will deepen rural penetration and ensure pan-India coverage across all states and Union Territories,” a statement said. The move is expected to support government initiatives focused on affordable healthcare and improved access to essential medicines.
Also Read: How Digital Maturity is Powering Pharma's GMP Evolution
HLL Lifecare has already established a strong base with its existing Amrit Pharmacies, known for offering high-quality medicines at lower costs compared to traditional retail outlets. The company plans to leverage this foundation to penetrate underserved markets, ensuring that healthcare is not just urban-centric but available to semi-urban and rural areas as well.
The Amrit Pharmacy network expansion is a significant step for HLL Lifecare as it seeks to balance business growth with social responsibility. By increasing the number of outlets, the company intends to serve more communities while promoting health awareness and wellness across the country.
With this initiative, HLL Lifecare is positioning itself as a key player in India’s pharmaceutical retail market, combining affordability, accessibility, and trust. The company expects the expansion to create new jobs, enhance supply chain efficiency, and contribute to strengthening India’s healthcare infrastructure in the coming years.
